Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies. Reinhorn D, Moskovitz M, Tap WD, Li BT, et al. Cancer 2025;131 Suppl 1:e35780.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Reinhorn D, Moskovitz M, Tap WD, Li BT, et al. Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies. Cancer 2025;131 Suppl 1:e35780.
PMID: 40171885